Degradation Signals for Ubiquitin-Proteasome Dependent Cytosolic Protein Quality Control (CytoQC) in Yeast

by Matthew J. Maurer, Eric D. Spear, Allen T. Yu, Evan J. Lee, Saba Shahzad, Susan Michaelis
Published 2016-07-01

JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis

by Kang Le, Linda E. Wellik, Matthew J. Maurer, Ellen D. McPhail, Thomas E. Witzig, Mamta Gupta
Published 2021-03-01

Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A.

by Diogo Torres, Xiaonan Hou, Laurie Bale, Ethan P Heinzen, Matthew J Maurer, Valentina Zanfagnin, Ann L Oberg, Cheryl Conover, S John Weroha
Published 2019-01-01

The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.

by Claudia C Preston, Matthew J Maurer, Ann L Oberg, Daniel W Visscher, Kimberly R Kalli, Lynn C Hartmann, Ellen L Goode, Keith L Knutson
Published 2013-01-01

Selection of chromosomal DNA libraries using a multiplex CRISPR system

by Owen W Ryan, Jeffrey M Skerker, Matthew J Maurer, Xin Li, Jordan C Tsai, Snigdha Poddar, Michael E Lee, Will DeLoache, John E Dueber, Adam P Arkin, Jamie HD Cate
Published 2014-08-01

Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era

by Arushi Khurana, Raphael Mwangi, Stephen M. Ansell, Thomas M. Habermann, James R. Cerhan, Christopher Strouse, Brian K. Link, Yucai Wang, Rebecca L. King, William R. Macon, J. C. Villasboas, Thomas E. Witzig, Matthew J. Maurer, Grzegorz S. Nowakowski
Published 2021-07-01

Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting

by Ann L. Oberg, Ethan P. Heinzen, Xiaonan Hou, Mariam M. Al Hilli, Rachel M. Hurley, Andrea E. Wahner Hendrickson, Krista M. Goergen, Melissa C. Larson, Marc A. Becker, Jeanette E. Eckel-Passow, Matthew J. Maurer, Scott H. Kaufmann, Paul Haluska, S. John Weroha
Published 2021-04-01

Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria

by Rebecca L. King, Arushi Khurana, Raphael Mwangi, Angelo Fama, Kay M. Ristow, Matthew J. Maurer, William R. Macon, Stephen M. Ansell, N. Nora Bennani, Yogish C. Kudva, Randall C. Walker, Kymberly D. Watt, Thomas R. Schwab, Sudhir S. Kushwaha, James R. Cerhan, Thomas M. Habermann
Published 2021-10-01

Inherited variants in regulatory T cell genes and outcome of ovarian cancer.

by Ellen L Goode, Melissa DeRycke, Kimberly R Kalli, Ann L Oberg, Julie M Cunningham, Matthew J Maurer, Brooke L Fridley, Sebastian M Armasu, Daniel J Serie, Priya Ramar, Krista Goergen, Robert A Vierkant, David N Rider, Hugues Sicotte, Chen Wang, Boris Winterhoff, Catherine M Phelan, Joellen M Schildkraut, Rachel P Weber, Ed Iversen, Andrew Berchuck, Rebecca Sutphen, Michael J Birrer, Shalaka Hampras, Leah Preus, Simon A Gayther, Susan J Ramus, Nicolas Wentzensen, Hannah P Yang, Montserrat Garcia-Closas, Honglin Song, Jonathan Tyrer, Paul P D Pharoah, Gottfried Konecny, Thomas A Sellers, Roberta B Ness, Lara E Sucheston, Kunle Odunsi, Lynn C Hartmann, Kirsten B Moysich, Keith L Knutson
Published 2013-01-01